Novel Pd(II) Rollover Complexes with Antimicrobial and Antibiofilm Activity
- 1University of Sassari , , via Vienna 2 , ,
- 2Consorzio Interuniversitario Reattività Chimica e Catalisi (CIRCC) , ,
- 3University of Cagliari , , ,
Abstract
The escalating global crisis of antimicrobial resistance (AMR) urgently demands the development of structurally diverse antimicrobial agents with novel mechanisms of action, including metal-based compounds. Herein, we report the synthesis and characterization of a series of palladium(II) complexes incorporating the 2-(2′-pyridyl)quinoline (pyqui) ligand. In addition to a simple N^N adduct [Pd(pyqui)(OAc)2] (1), rollover cyclometalation allowed the synthesis of less-common rollover-cyclometalated dimers [Pd(pyqui-H)(μ-OAc)]2 (2) and [Pd(pyqui-H)(μ-Cl)]2 (3), and mononuclear rollover derivatives [Pd(pyqui-H)(OAc)(PPh3)] (4) and [Pd(pyqui-H)(Cl)(PPh3)] (5). The new compounds were comprehensively characterized by elemental analysis, FT-IR spectroscopy, and multinuclear (1H, 13C, 31P) NMR spectroscopy, including two-dimensional experiments. Dynamic NMR studies revealed the coexistence of transoid and cisoid isomers in solution for the cyclometalated dimer 2. The antimicrobial and antibiofilm properties of the complexes were evaluated against clinically relevant Gram-positive bacteria (Staphylococcus aureus, Streptococcus pyogenes), Gram-negative bacteria (Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli), and the fungal pathogen Candida albicans, using agar well diffusion, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum biofilm inhibitory concentration (MBIC) assays. The rollover mononuclear complexes 4 and 5 were the most active compounds, exhibiting broad-spectrum antibacterial activity together with significant antibiofilm effects, particularly against Gram-positive pathogens.
Related
- Integrated Experimental and Computational Evaluation of Tri(p‐tolyl)phosphonium–Hydrazide Salts as AChE Inhibitors With Antimicrobial and Antibiofilm Activity Against Resistant Acinetobacter baumannii
- Room temperature synthesis of novel azine-linked covalent organic framework: molecular docking, theoretical investigation studies, and antimicrobial activity
- Antimicrobial activity and ADMET analysis of novel coumarin-based pyridine and pyran hybrids
- 2D/3D-QSAR-guided design of novel 1,2,4-triazole derivatives with predicted enhanced antimicrobial activity.
- Robust marine bacterium-mediated synthesis of Cu-ZnO nanocomposites: a novel antibiofilm and antivirulent strategy to combat carbapenem-resistant Acinetobacter baumannii
BibTeX
@article{zucca2026novel,
title = {{Novel Pd(II) Rollover Complexes with Antimicrobial and Antibiofilm Activity}},
author = {Antonio Zucca and Bruna Canu and Giacomo Senzacqua and Sergio Stoccoro and Maria I. Pilo and Germano Orrù and Diletta Raspizzu and Alessandra Scano},
journal = {ACS Omega},
year = {2026},
month = nov,
doi = {10.1021/acsomega.6c09421},
url = {https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c09421/5468371/Novel-Pd-II-Rollover-Complexes-with-Antimicrobial},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Novel Pd(II) Rollover Complexes with Antimicrobial and Antibiofilm Activity
AU - Antonio Zucca
AU - Bruna Canu
AU - Giacomo Senzacqua
AU - Sergio Stoccoro
AU - Maria I. Pilo
AU - Germano Orrù
AU - Diletta Raspizzu
AU - Alessandra Scano
PY - 2026
DA - 2026/11/11
JO - ACS Omega
DO - 10.1021/acsomega.6c09421
UR - https://pubs.acs.org/acsodf/article/doi/10.1021/acsomega.6c09421/5468371/Novel-Pd-II-Rollover-Complexes-with-Antimicrobial
AB - The escalating global crisis of antimicrobial resistance (AMR) urgently demands the development of structurally diverse antimicrobial agents with novel mechanisms of action, including metal-based compounds. Herein, we report the synthesis and characterization of a series of palladium(II) complexes incorporating the 2-(2′-pyridyl)quinoline (pyqui) ligand. In addition to a simple N^N adduct [Pd(pyqui)(OAc)2] (1), rollover cyclometalation allowed the synthesis of less-common rollover-cyclometalated dimers [Pd(pyqui-H)(μ-OAc)]2 (2) and [Pd(pyqui-H)(μ-Cl)]2 (3), and mononuclear rollover derivatives [Pd(pyqui-H)(OAc)(PPh3)] (4) and [Pd(pyqui-H)(Cl)(PPh3)] (5). The new compounds were comprehensively characterized by elemental analysis, FT-IR spectroscopy, and multinuclear (1H, 13C, 31P) NMR spectroscopy, including two-dimensional experiments. Dynamic NMR studies revealed the coexistence of transoid and cisoid isomers in solution for the cyclometalated dimer 2. The antimicrobial and antibiofilm properties of the complexes were evaluated against clinically relevant Gram-positive bacteria (Staphylococcus aureus, Streptococcus pyogenes), Gram-negative bacteria (Pseudomonas aeruginosa, Klebsiella pneumoniae, Escherichia coli), and the fungal pathogen Candida albicans, using agar well diffusion, minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC), and minimum biofilm inhibitory concentration (MBIC) assays. The rollover mononuclear complexes 4 and 5 were the most active compounds, exhibiting broad-spectrum antibacterial activity together with significant antibiofilm effects, particularly against Gram-positive pathogens.
SN - 2470-1343
ER -